Sotera Health Co (SHC)

Sotera Health Co. experienced significant insider trading activity recently, with executives offloading shares following a positive earnings report. CEO Michael Petras and President Michael Rutz executed multiple sales totaling over 48 million dollars. These divestments occurred as the stock price climbed, reflecting a strong performance trend within the healthcare sector over the last quarter.
Ticker: SHC Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Sotera Health Co. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Petras Michael B. Jr. Executive Chairman Executive Director
Transaction date
Sale
Price
326.60
Quantity 89,917 +33.1%
Value US$2,372,489
3.5
Petras Michael B. Jr. Executive Chairman Executive Director
Transaction date
Sale
Price
460.97
Quantity 56,479 -6.8%
Value US$4,976,608
3.5
Michael B. Petras, Jr. Chairman, CEO
Transaction date
Proposed sale
Price
202.89
Quantity 1,200
Value US$3,643,124
2.6
Rutz Michael P President of Sterigenics Officer
Transaction date
Sale
Price
18.84
Quantity 150,000 -31.0%
Value US$2,825,250
2.6
Rutz Michael P Officer Officer
Transaction date
Proposed sale
Price
18.91
Quantity 150,000
Value US$2,836,500
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.17
Quantity 19,102,952 -100.0%
Value US$289,753,576
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.17
Quantity 19,102,952 -100.0%
Value US$289,753,576
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.17
Quantity 12,735,301 -100.0%
Value US$193,169,046
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.17
Quantity 12,735,301 -100.0%
Value US$193,169,046
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.17
Quantity 19,102,952 -100.0%
Value US$289,753,576
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.27
Quantity 10,000,000 -44.0%
Value US$152,700,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.27
Quantity 15,000,000 -44.0%
Value US$229,050,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.27
Quantity 15,000,000 -44.0%
Value US$229,050,000
3.5
Petras Michael B. Jr. Chairman & CEO Executive Director
Transaction date
Sale
Price
16.45
Quantity 39,243 -100.0%
Value US$645,547
3.5
Petras Michael B. Jr. Chairman & CEO Executive Director
Transaction date
Sale
Price
16.45
Quantity 394,861 -7.6%
Value US$6,495,463
3.5
Petras Michael B. Jr. Chairman & CEO Executive Director
Transaction date
Sale
Price
16.45
Quantity 315,896 -36.4%
Value US$5,196,489
3.5
Michael B. Petras, Jr. Chairman, CEO
Transaction date
Proposed sale
Price
16.75
Quantity 750,000
Value US$12,562,500
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
16.33
Quantity 9,720,000 -22.2%
Value US$158,727,600
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
16.33
Quantity 9,720,000 -22.2%
Value US$158,727,600
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
16.33
Quantity 6,480,000 -22.2%
Value US$105,818,400
Transaction date
Proposed sale
Price
16.33
Quantity 1,295,747
Value US$21,159,549
Transaction date
Proposed sale
Price
16.33
Quantity 41,219
Value US$673,106
Transaction date
Proposed sale
Price
16.33
Quantity 5,143,033
Value US$83,985,729
3.3
WARBURG PINCUS LLC Affiliate
Transaction date
Proposed sale
Price
16.84
Quantity 9,720,000
Value US$163,684,800
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.65
Quantity 12,000,000 -29.1%
Value US$187,812,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.65
Quantity 18,000,000 -29.1%
Value US$281,718,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.65
Quantity 18,000,000 -29.1%
Value US$281,718,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.11
Quantity 12,000,000 -16.3%
Value US$181,332,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.11
Quantity 12,000,000 -16.3%
Value US$181,332,000
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.11
Quantity 8,000,000 -16.3%
Value US$120,888,000
2.6
Rutz Michael P President of Sterigenics Officer
Transaction date
Sale
Price
16.38
Quantity 126,611 -22.0%
Value US$2,074,306
2.6
Rutz Michael P Officer Officer
Transaction date
Proposed sale
Price
16.12
Quantity 126,611
Value US$2,040,969
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.03
Quantity 10,000,000 -16.9%
Value US$150,300,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.03
Quantity 15,000,000 -16.9%
Value US$225,450,000
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
15.03
Quantity 15,000,000 -16.9%
Value US$225,450,000
3.2
Klee Ann R. Non-Executive Director
Transaction date
Sale
Price
14.31
Quantity 5,750 -6.2%
Value US$82,268
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
14.31
Quantity 16,594,363 -15.7%
Value US$237,423,849
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
14.31
Quantity 16,594,363 -15.7%
Value US$237,423,849
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
14.31
Quantity 11,062,908 -15.7%
Value US$158,282,556
3.5
Petras Michael B. Jr. Chairman & CEO Officer
Transaction date
Sale
Price
14.31
Quantity 1,003,870 -15.5%
Value US$14,362,870
2.6
Rutz Michael P President of Sterigenics Officer
Transaction date
Sale
Price
14.31
Quantity 83,109 -13.2%
Value US$1,189,082
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
26.12
Quantity 13,512,582 -11.4%
Value US$352,982,423
3.5
Petras Michael B. Jr. Chairman & CEO Executive Director
Transaction date
Sale
Price
26.12
Quantity 817,439 -11.4%
Value US$21,353,550
2.9
Klaben Matthew J SVP, GC and Secretary Officer
Transaction date
Sale
Price
26.12
Quantity 41,952 -11.4%
Value US$1,095,891
2.8
WARBURG PINCUS & CO. Non-Executive Director Large shareholder
Transaction date
Sale
Price
26.12
Quantity 13,512,582 -11.4%
Value US$352,982,423
2.9
GTCR INVESTMENT XI LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
26.12
Quantity 9,008,388 -11.4%
Value US$235,321,616
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-19 2026-08-17 S Sale

Executive Chairman

Executive Director
89,917 +33.1%
326.60
US$2,372,489
89,917 +33.1% 326.60 US$2,372,489
2026-08-19 2026-08-17 S Sale

Executive Chairman

Executive Director
56,479 -6.8%
460.97
US$4,976,608
56,479 -6.8% 460.97 US$4,976,608
2026-08-17 2026-08-17 PrS Proposed sale

Chairman, CEO

1,200
202.89
US$3,643,124
1,200 202.89 US$3,643,124
2026-08-11 2026-08-07 S Sale

President of Sterigenics

Officer
150,000 -31.0%
18.84
US$2,825,250
150,000 -31.0% 18.84 US$2,825,250
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
150,000
18.91
US$2,836,500
150,000 18.91 US$2,836,500
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
19,102,952 -100.0%
15.17
US$289,753,576
19,102,952 -100.0% 15.17 US$289,753,576
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
19,102,952 -100.0%
15.17
US$289,753,576
19,102,952 -100.0% 15.17 US$289,753,576
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
12,735,301 -100.0%
15.17
US$193,169,046
12,735,301 -100.0% 15.17 US$193,169,046
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
12,735,301 -100.0%
15.17
US$193,169,046
12,735,301 -100.0% 15.17 US$193,169,046
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
19,102,952 -100.0%
15.17
US$289,753,576
19,102,952 -100.0% 15.17 US$289,753,576
2026-03-10 2026-03-06 S Sale Non-Executive Director Large shareholder
10,000,000 -44.0%
15.27
US$152,700,000
10,000,000 -44.0% 15.27 US$152,700,000
2026-03-10 2026-03-06 S Sale Non-Executive Director Large shareholder
15,000,000 -44.0%
15.27
US$229,050,000
15,000,000 -44.0% 15.27 US$229,050,000
2026-03-10 2026-03-06 S Sale Non-Executive Director Large shareholder
15,000,000 -44.0%
15.27
US$229,050,000
15,000,000 -44.0% 15.27 US$229,050,000
2025-12-10 2025-12-08 S Sale

Chairman & CEO

Executive Director
39,243 -100.0%
16.45
US$645,547
39,243 -100.0% 16.45 US$645,547
2025-12-10 2025-12-08 S Sale

Chairman & CEO

Executive Director
394,861 -7.6%
16.45
US$6,495,463
394,861 -7.6% 16.45 US$6,495,463
2025-12-10 2025-12-08 S Sale

Chairman & CEO

Executive Director
315,896 -36.4%
16.45
US$5,196,489
315,896 -36.4% 16.45 US$5,196,489
2025-12-08 2025-12-08 PrS Proposed sale

Chairman, CEO

750,000
16.75
US$12,562,500
750,000 16.75 US$12,562,500
2025-12-05 2025-12-03 S Sale Non-Executive Director Large shareholder
9,720,000 -22.2%
16.33
US$158,727,600
9,720,000 -22.2% 16.33 US$158,727,600
2025-12-05 2025-12-03 S Sale Non-Executive Director Large shareholder
9,720,000 -22.2%
16.33
US$158,727,600
9,720,000 -22.2% 16.33 US$158,727,600
2025-12-05 2025-12-03 S Sale Non-Executive Director Large shareholder
6,480,000 -22.2%
16.33
US$105,818,400
6,480,000 -22.2% 16.33 US$105,818,400
2025-12-04 2025-12-03 PrS Proposed sale

Owner

1,295,747
16.33
US$21,159,549
1,295,747 16.33 US$21,159,549
2025-12-03 2025-12-03 PrS Proposed sale

Owner

41,219
16.33
US$673,106
41,219 16.33 US$673,106
2025-12-03 2025-12-03 PrS Proposed sale

Owner

5,143,033
16.33
US$83,985,729
5,143,033 16.33 US$83,985,729
2025-12-03 2025-12-03 PrS Proposed sale

Affiliate

9,720,000
16.84
US$163,684,800
9,720,000 16.84 US$163,684,800
2025-11-12 2025-11-10 S Sale Non-Executive Director Large shareholder
12,000,000 -29.1%
15.65
US$187,812,000
12,000,000 -29.1% 15.65 US$187,812,000
2025-11-12 2025-11-10 S Sale Non-Executive Director Large shareholder
18,000,000 -29.1%
15.65
US$281,718,000
18,000,000 -29.1% 15.65 US$281,718,000
2025-11-12 2025-11-10 S Sale Non-Executive Director Large shareholder
18,000,000 -29.1%
15.65
US$281,718,000
18,000,000 -29.1% 15.65 US$281,718,000
2025-09-09 2025-09-05 S Sale Non-Executive Director Large shareholder
12,000,000 -16.3%
15.11
US$181,332,000
12,000,000 -16.3% 15.11 US$181,332,000
2025-09-09 2025-09-05 S Sale Non-Executive Director Large shareholder
12,000,000 -16.3%
15.11
US$181,332,000
12,000,000 -16.3% 15.11 US$181,332,000
2025-09-09 2025-09-05 S Sale Non-Executive Director Large shareholder
8,000,000 -16.3%
15.11
US$120,888,000
8,000,000 -16.3% 15.11 US$120,888,000
2025-08-26 2025-08-22 S Sale

President of Sterigenics

Officer
126,611 -22.0%
16.38
US$2,074,306
126,611 -22.0% 16.38 US$2,074,306
2025-08-22 2025-08-22 PrS Proposed sale

Officer

Officer
126,611
16.12
US$2,040,969
126,611 16.12 US$2,040,969
2024-09-09 2024-09-06 S Sale Non-Executive Director Large shareholder
10,000,000 -16.9%
15.03
US$150,300,000
10,000,000 -16.9% 15.03 US$150,300,000
2024-09-09 2024-09-06 S Sale Non-Executive Director Large shareholder
15,000,000 -16.9%
15.03
US$225,450,000
15,000,000 -16.9% 15.03 US$225,450,000
2024-09-09 2024-09-06 S Sale Non-Executive Director Large shareholder
15,000,000 -16.9%
15.03
US$225,450,000
15,000,000 -16.9% 15.03 US$225,450,000
2024-03-06 2024-03-04 S Sale Non-Executive Director
5,750 -6.2%
14.31
US$82,268
5,750 -6.2% 14.31 US$82,268
2024-03-06 2024-03-04 S Sale Non-Executive Director Large shareholder
16,594,363 -15.7%
14.31
US$237,423,849
16,594,363 -15.7% 14.31 US$237,423,849
2024-03-06 2024-03-04 S Sale Non-Executive Director Large shareholder
16,594,363 -15.7%
14.31
US$237,423,849
16,594,363 -15.7% 14.31 US$237,423,849
2024-03-06 2024-03-04 S Sale Non-Executive Director Large shareholder
11,062,908 -15.7%
14.31
US$158,282,556
11,062,908 -15.7% 14.31 US$158,282,556
2024-03-05 2024-03-04 S Sale

Chairman & CEO

Officer
1,003,870 -15.5%
14.31
US$14,362,870
1,003,870 -15.5% 14.31 US$14,362,870
2024-03-05 2024-03-04 S Sale

President of Sterigenics

Officer
83,109 -13.2%
14.31
US$1,189,082
83,109 -13.2% 14.31 US$1,189,082
2021-03-24 2021-03-22 S Sale Non-Executive Director Large shareholder
13,512,582 -11.4%
26.12
US$352,982,423
13,512,582 -11.4% 26.12 US$352,982,423
2021-03-24 2021-03-22 S Sale

Chairman & CEO

Executive Director
817,439 -11.4%
26.12
US$21,353,550
817,439 -11.4% 26.12 US$21,353,550
2021-03-24 2021-03-22 S Sale

SVP, GC and Secretary

Officer
41,952 -11.4%
26.12
US$1,095,891
41,952 -11.4% 26.12 US$1,095,891
2021-03-24 2021-03-22 S Sale Non-Executive Director Large shareholder
13,512,582 -11.4%
26.12
US$352,982,423
13,512,582 -11.4% 26.12 US$352,982,423
2021-03-24 2021-03-22 S Sale Non-Executive Director Large shareholder
9,008,388 -11.4%
26.12
US$235,321,616
9,008,388 -11.4% 26.12 US$235,321,616